Streetbeat News

Analyst Ratings

NBIX

Canaccord Genuity analyst Sumant Kulkarni maintains a 'Buy' rating on Neurocrine Biosciences (NASDAQ:NBIX) and raises the price target from $132 to $144.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 4:17 pm

TASK

Baird analyst David Koning maintains an Outperform rating on TaskUs (NASDAQ:TASK) but has lowered the price target from $14 to $12.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 4:16 pm

NVDA

SPY

Economist Philip Pilkington suggests that the US economic growth data may be artificially inflated due to the Biden administration's Infrastructure Investment and Jobs Act (IRA), which has spurred a construction boom. He argues that the US economy is being propped up by construction spending, supported by IRA subsidies, and questions whether this can continue until the election. Amid this uncertainty, investors are advised to bet on top-performing companies and hedge against potential market downturns. An example of a hedged portfolio is provided, which includes Nvidia, Inc. (NASDAQ:NVDA) and outperformed the SPDR S&P 500 Trust ETF (NYSE:SPY) over a six-month period.

Portfolio Pulse from David Pinsen

September 13, 2023 | 4:15 pm

CRWD

Barclays analyst Saket Kalia maintains an Overweight rating on CrowdStrike Holdings (NASDAQ:CRWD) and raises the price target from $173 to $186.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 4:14 pm

APTV

UBS analyst Joseph Spak has initiated coverage on Aptiv (NYSE:APTV) with a Buy rating and a price target of $143.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 4:12 pm

F

UBS analyst Joseph Spak has initiated coverage on Ford Motor (NYSE:F) with a Buy rating and a price target of $15.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 4:10 pm

ACELYRIN

ACELYRIN's stock is trading lower following a downgrade by Morgan Stanley from Overweight to Equal-Weight. This comes after the company's Part B of a Phase 2b/3 trial of izokibep for Hidradenitis Suppurativa failed to meet its primary endpoint.

Portfolio Pulse from Bill Haddad

September 13, 2023 | 4:08 pm

VEEV

Barclays analyst Saket Kalia maintains an Overweight rating on Veeva Systems (VEEV) and raises the price target from $227 to $250.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 4:07 pm

AAPL

AVGO

CRUS

QCOM

QRVO

SWKS

Apple Inc. unveiled the iPhone 15 and other product updates at its Wonderlust event. Analysts from Bank of America, Goldman Sachs, Morgan Stanley, KeyBanc Capital Markets, Needham, Bernstein, and Wedbush provided their reactions and expectations for Apple's stock. The analysts highlighted the unchanged pricing for the iPhone 15, potential benefits for average sale prices, and concerns about China banning iPhone use by government staff. The event could also have implications for Apple suppliers such as Broadcom, Cirrus Logic, Qorvo, Qualcomm, and Skyworks Solutions.

Portfolio Pulse from Chris Katje

September 13, 2023 | 4:06 pm

JBHT

J.B. Hunt Transport Services is set to present at the Morgan Stanley 11th Annual Laguna Conference.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 4:03 pm